Related Experiment Videos
Electron-deficient isoalloxazines: model systems for disulfide prodrug formation
1Department of Pharmaceutical Chemistry, School of Pharmacy, University of California, San Francisco 94143-0446.
Journal of Medicinal Chemistry
|July 1, 1991
Summary
Novel isoalloxazine catalysts facilitate the synthesis of disulfide prodrugs by efficiently oxidizing thiophenols. Electron-deficient isoalloxazines with specific side chains show the highest catalytic activity, offering a promising route to safer drug development.
Area of Science:
- Medicinal Chemistry
- Organic Synthesis
- Catalysis
Background:
- Drugs with thiol groups can form reactive metabolites, leading to adverse effects.
- Developing new catalysts is crucial for synthesizing disulfide prodrugs to mitigate these side effects.
Purpose of the Study:
- To investigate the synthesis, structure-activity relationships, and reaction mechanisms of isoalloxazine-based catalysts.
- To explore the oxidation of thiophenols using novel isoalloxazine disulfide formation catalysts.
Main Methods:
- Synthesis of various substituted isoalloxazines, including electron-deficient and non-electron-deficient variants.
- Reaction of model thiophenols (m-nitrothiophenol) with synthesized isoalloxazines.
- Kinetic and product studies to determine catalytic efficiency and elucidate reaction mechanisms.
Main Results:
- Electron-deficient isoalloxazines with an N-3-mercaptoalkyl side chain were the most effective catalysts for m-nitrothiophenol disulfide formation.
- Isoalloxazines lacking the N-3-alkyl mercaptan side chain showed significantly reduced or no catalytic activity.
- Catalytic activity differences were attributed to variations in isoalloxazine chemical properties and their ability to stabilize intramolecular thiol attack.
Conclusions:
- Electron-deficient isoalloxazines featuring an N-3-mercaptoalkyl side chain are efficient catalysts for thiophenol oxidation.
- These findings suggest that electron-deficient isoalloxazines hold potential as valuable catalysts in the synthesis of disulfide prodrugs.